Proximity to livestock farms and COVID-19 in the Netherlands, 2020-2021.

Autor: Hogerwerf L; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: lenny.hogerwerf@rivm.nl., Post PM; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands; Department of Natural Resources, Faculty of Geo-Information Science and Earth Observation (ITC), University of Twente, P.O Box 217, Enschede, 7500 AE, the Netherlands. Electronic address: p.m.post@utwente.nl., Bom B; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: ben.bom@rivm.nl., van der Hoek W; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: hoek8724@planet.nl., van de Kassteele J; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: jan.van.de.kassteele@rivm.nl., Stemerding AM; Deventer Hospital, P.O. Box 5001, 7400 GC, Deventer, the Netherlands. Electronic address: annette.m.stemerding@gmail.com., de Vries W; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: wilco.de.vries@rivm.nl., Houthuijs D; National Institute for Public Health and the Environment (RIVM), P.O. Box 1, 3720 BA, Bilthoven, the Netherlands. Electronic address: danny.houthuijs@rivm.nl.

Publikováno v: International journal of hygiene and environmental health [Int J Hyg Environ Health] 2022 Aug; Vol. 245, pp. 114022. Date of Electronic Publication: 2022 Aug 15.

Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension.

Autor: Cooper N; Imperial College London, London, UK., Bussel JB; Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, USA., Kaźmierczak M; Poznań University of Medical Sciences, Poznań, Poland., Miyakawa Y; Saitama Medical University, Saitama, Japan., Cluck S; UCB, Slough, UK., Lledó García R; UCB, Slough, UK., Haier B; UCB, Monheim, Germany., Lavrov A; UCB, Monheim, Germany., Singh P; UCB, Slough, UK., Snipes R; UCB, Morrisville, North Carolina, USA., Kuter DJ; Hematology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The multiple facets of FcRn in immunity.

Autor: Stapleton NM; Sanquin Research and Landsteiner Laboratory, Amsterdam Medical Centre, Amsterdam, The Netherlands., Einarsdóttir HK; Sanquin Research and Landsteiner Laboratory, Amsterdam Medical Centre, Amsterdam, The Netherlands., Stemerding AM; Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Vidarsson G; Sanquin Research and Landsteiner Laboratory, Amsterdam Medical Centre, Amsterdam, The Netherlands.

Publikováno v: Immunological reviews [Immunol Rev] 2015 Nov; Vol. 268 (1), pp. 253-68.

IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy.

Autor: Kallolimath, Somanath, Sun, Lin, Palt, Roman, Föderl-Höbenreich, Esther, Hermle, Antonia, Voss, Leonie, Kleim, Marina, Nimmerjahn, Falk, Gach, Johannes S., Hitchcock, Lauren, Chen, Qiang, Melnik, Stanislav, Eminger, Florian, Lux, Anja, Steinkellner, Herta

Publikováno v: Frontiers in Immunology; 2024, p1-13, 13p